Literature DB >> 9575214

Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis.

E Masliah1, J Raber, M Alford, M Mallory, M P Mattson, D Yang, D Wong, L Mucke.   

Abstract

Excitatory neurotransmitters such as glutamate are required for the normal functioning of the central nervous system but can trigger excitotoxic neuronal injury if allowed to accumulate to abnormally high levels. Their extracellular levels are controlled primarily by transmitter uptake into astrocytes. Here, we demonstrate that the amyloid protein precursor may participate in the regulation of this important process. The amyloid protein precursor has been well conserved through evolution, and a number of studies indicate that it may function as an endogenous excitoprotectant. However, the mechanisms underlying this neuroprotective capacity remain largely unknown. At moderate levels of expression, human amyloid protein precursors increased glutamate/aspartate uptake in brains of transgenic mice, with the 751-amino acid isoform showing greater potency than the 695-amino acid isoform. Cerebral glutamate/aspartate transporter protein levels were higher in transgenic mice than in non-transgenic controls, whereas transporter mRNA levels were unchanged. Amyloid protein precursor-dependent stimulation of aspartate uptake by cultured primary astrocytes was associated with increases in protein kinase A and C activity and could be blocked by inhibitors of these kinases. The stimulation of astroglial excitatory amino acid transport by amyloid protein precursors could protect the brain against excitotoxicity and may play an important role in neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575214     DOI: 10.1074/jbc.273.20.12548

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.

Authors:  R Planells-Cases; M Caprini; J Zhang; E M Rockenstein; R R Rivera; C Murre; E Masliah; M Montal
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

2.  Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions.

Authors:  Marcos Emílo dos Santos Frizzo; Diogo Rizzato Lara; Alexandre de Souza Prokopiuk; Carmen Regla Vargas; Christianne Gazzana Salbego; Moacir Wajner; Diogo Onofre Souza
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 3.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 7.  Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.

Authors:  Makoto Hashimoto; Eliezer Masliah
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

8.  Enmein Decreases Synaptic Glutamate Release and Protects against Kainic Acid-Induced Brain Injury in Rats.

Authors:  Cheng-Wei Lu; Yu-Chen Huang; Kuan-Ming Chiu; Ming-Yi Lee; Tzu-Yu Lin; Su-Jane Wang
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

Review 9.  Overview of Glutamatergic Dysregulation in Central Pathologies.

Authors:  Tanya Miladinovic; Mina G Nashed; Gurmit Singh
Journal:  Biomolecules       Date:  2015-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.